Jie Hu

Dr. Jie Hu

Suzhou DiYinAn Biotech Co., Ltd. & Suzhou Innovation Centre for Life Science & Technology, Suzhou 215129, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2023 in Talanta
Verified
Journal Article
Closed access
BJBirui Jin
Birui Jin
ZDZhiguo Du
Zhiguo Du
JJJingcheng Ji
Jingcheng Ji
YBYuemeng Bai
Yuemeng Bai
DTDeding Tang
Deding Tang
ZLZedong Li
Zedong Li

5 March 2024 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
BJBirui Jin
Birui Jin
CMChuan Ma
Chuan Ma
CZChuyao Zhang
Chuyao Zhang
HYHuiling Yin
Huiling Yin
GZGuoxu Zhao
Guoxu Zhao
ZLZedong Li
Zedong Li

7 November 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
BJBirui Jin
Birui Jin
ZDZhiguo Du
Zhiguo Du
CZChuyao Zhang
Chuyao Zhang
ZYZhao Yu
Zhao Yu
XWXuemin Wang
Xuemin Wang
ZLZedong Li
Zedong Li
Inflammation caused by viral or bacterial infection is a major threat to human health globally. Blood C-reactive protein (CRP) has been proven to be a sensitive indicator for the occurrence and development of inflammation. Furthermore, a tiny change of blood CRP concentration may portend chronic diseases; therefore, high-sensitivity CRP (hs-CRP) detection in a quantitative, rapid, user-friendly, and low-cost manner is highly demanded. In this paper, we developed a europium-chelate polystyrene microsphere (EuPSM)-based lateral flow immunoassay (LFIA) integrating with a benchtop fluorescence analyzer for hs-CRP detection. The optimization of the EuPSM-based LFIA was implemented through adjusting the antibody density on EuPSM from 100% to 60% of the saturated density. Finally, the limit of detection of 0.76 pg/mL and detection range of 0.025–250 ng/mL were obtained. Moreover, the clinical application capability of the proposed platform was validated through detecting CRP in clinical serum samples, showing high consistency with the results obtained from the clinical standard method. Hence, the proposed EuPSM-based LFIA has been verified to be well suitable for hs-CRP detection, while also showing great applicability for sensitively and rapidly detecting other biomarkers.

7 October 2024 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
BJBirui Jin
Birui Jin
SLSiyu Li
Siyu Li
CZChuyao Zhang
Chuyao Zhang
CMChuan Ma
Chuan Ma
Jie HuJie Hu
Jie Hu
ZLZedong Li
Zedong Li

8 August 2024 in Biosensors
Verified
Journal Article
Open access
PDF file
DTDding Tang Tang
Dding Tang Tang
SWShuang Wu
Shuang Wu
MKMengqi Kong
Mengqi Kong
ZLZhaonan Liu
Zhaonan Liu
ZLZonghao Li
Zonghao Li
Jie HuJie Hu
Jie Hu
Exercise-induced muscle injury is one of the most common types of sports injuries. Skeletal muscle troponin I (skTnI) serves as an ideal biomarker in assessing such injuries, facilitating timely detection and evaluation. In this study, we develop a fluorescent sandwich lateral flow immunoassay (LFIA) combined with a desktop analyzer for rapid detection of skTnI. Through optimizing the reaction system, the assay achieves a satisfying detection performance, reaching a limit of detection (LOD) of 0.5 ng/mL with a turnaround time of 15 min. The proposed detection platform offers portability, ease of use, and high sensitivity, which facilitates the monitoring of exercise-induced muscle injuries at the point of care. This feature is particularly advantageous for end users, enabling timely detection of sports-related injuries and ultimately enhancing prognosis and sports life.

26 June 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
DTDding Tang Tang
Dding Tang Tang
SWShuang Wu
Shuang Wu
MKMeng Qi Kong
Meng Qi Kong
ZLZhao Nan Liu
Zhao Nan Liu
NCning chang
ning chang
Jie HuJie Hu
Jie Hu
Exercise-induced muscle injury is one of the most common types of sports injuries. Skeletal muscle troponin I (skTnI) serves as an ideal biomarker in assessing such injuries, facilitating timely detection and evaluation. In this study, we develop a fluorescent sandwich lateral flow immunoassay (LFIA) combined with a desktop analyzer for rapid detection of skTnI. Through optimizing the reaction system, the assay achieves a satisfying detection performance, reaching a limit of detection (LOD) of 0.5 ng/mL with a turnaround time of 15 minutes. The proposed de-tection platform offers portability, ease of use, and high sensitivity, which facilitates the moni-toring of exercise-induced muscle injuries at the point of care. This feature is particularly advan-tageous for end-users, enabling timely detection of sports-related injuries and ultimately en-hancing prognosis and sports life.